Please login to the form below

Not currently logged in

Lilly expands its immuno-oncology work with $1.8bn CureVac deal

Eli Lilly HQWill work with the German firm to develop ‘next generation’ cancer vaccines

MSD touts Keytruda first-line promise in NSCLC

merck-keytruda-pembrolizumab-melanomaSays patients on the drug more than doubled median OS compared to chemo

AZ and MSD win FDA priority review for Lynparza in breast cancer

AstraZeneca AZCould become the first PARP inhibitor to be approved in the US for the disease

Court throws out Allergan's patent deal with Native American tribe

Allergan RestasisRules the contentious agreement can't protect its dry eye treatment Restasis


Moving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London


Signal strength

Communications that connect

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Janssen develops digital tools to help automate clinical trials

iSTEP platform combines mobile tech and smart packaging

Janssen scientists

Gilead Sciences promotes Dr Alessandro Riva to EVP, oncology therapeutics

He's been with the firm since January, when he joined from Novartis


Scancell appoints Dr Cliff Holloway as CEO

He joins the immunotherapy firm from Benitec Biopharma


FDA approves new robotic surgery device

Senhance System backed for colorectal and gynaecological operations

FDA headquarters White Oak

The patient’s world is ‘messy’

And therein lies the value for pharma

Jane Barrett

Price matters

But so does innovation

Featured jobs

Subscribe to our email news alerts


Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...